Table 1 Laboratory variables during follow-up a
Total calcium (mg/dl) | Phosphorus (mg/dl) | 25(OH)D (μg/L) | PTH (pg/ml) | Drugs used to manage calcium metabolism (dose/day) | |
|---|---|---|---|---|---|
Normal ranges | 8.4 to 10.2 | 3.5 to 5.0 | 30 to 80 | 10 to 65 | |
After RYGB and before TT | 9.0 | 4.2 | 64.4 | 27.9 | |
2 months post-TT | 5.9b | 7.1 | – | – | Calcium carbonate (7.5g) |
Calcitriol (2μg) | |||||
3 months post-TT | 6.2b | 6.8 | 76.6 | 7.1 | Calcium carbonate |
Calcitriol (2μg) | |||||
4 months post-TT | 6.8b | 6.8 | 16.4 | – | Calcium citrate (12g) |
Cholecalciferol (12,000IU) | |||||
Calcitriol (2μg) | |||||
6 months post-TT | 7.2b | 5.0 | – | – | Calcium citrate (12g) |
Cholecalciferol (12,000IU) | |||||
Calcitriol (2μg) | |||||
Pancrelipase (3 capsules/day) | |||||
8 months post-TT | 7.8b | 5.2 | 67.9 | 8.0 | Calcium citrate (14g) |
Cholecalciferol (12,000IU) | |||||
Calcitriol (2μg) | |||||
Pancrelipase (3 capsules/day) | |||||
14 months post-TT, pregnant second trimester | 7.1b | 5.2 | 49.2 | 5.9 | Calcium citrate (14g) |
Cholecalciferol (12,000IU) | |||||
Calcitriol (1.5μg) | |||||
Pancrelipase (3 capsules/day) | |||||
Last measurements | 8.8b | 5.1 | 34.8 | – | Calcium citrate (18g) |
Cholecalciferol (12,000IU) | |||||
Calcitriol (1.5μg) | |||||
Pancrelipase (3 capsules/day) |